{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:04:57Z","timestamp":1759334697467,"version":"build-2065373602"},"reference-count":42,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Medical Research"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1016\/j.arcmed.2006.12.010","type":"journal-article","created":{"date-parts":[[2007,7,5]],"date-time":"2007-07-05T14:07:41Z","timestamp":1183644461000},"page":"628-633","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Treatment of HCV in Patients with Renal Failure"],"prefix":"10.1016","volume":"38","author":[{"given":"Harmit","family":"Kalia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia M.","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.arcmed.2006.12.010_bib1","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1525-139X.2005.18108.x","article-title":"National surveillance of dialysis-associated diseases in the United States, 2002","volume":"18","author":"Finelli","year":"2005","journal-title":"Semin Dial"},{"key":"10.1016\/j.arcmed.2006.12.010_bib2","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1111\/j.1523-1755.2004.00649.x","article-title":"Patterns of HCV prevalence and seroconversion in hemodialysis units from three continents: the DOPPS Study","volume":"65","author":"Fissell","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/j.arcmed.2006.12.010_bib3","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1093\/ndt\/gfh012","article-title":"The changing epidemiology of hepatitis C virus (HCV) in hemodialysis: European multicenter study","volume":"19","author":"Jadoul","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.arcmed.2006.12.010_bib4","doi-asserted-by":"crossref","first-page":"c1","DOI":"10.1159\/000093252","article-title":"Effect of isolation measures on the incidence and prevalence of hepatitis C virus infection in hemodialysis","volume":"104","author":"Gallego","year":"2006","journal-title":"Nephron Clin Prac"},{"key":"10.1016\/j.arcmed.2006.12.010_bib5","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/jhep.2002.34613","article-title":"Hepatitis C infection and the patient with endstage renal disease","volume":"36","author":"Fabrizi","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2006.12.010_bib6","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/ki.1996.403","article-title":"ESRD patient mortality with adjustment for comorbid conditions in Lombardy (Italy) versus the United States","volume":"50","author":"Marcelli","year":"1996","journal-title":"Kidney Int"},{"key":"10.1016\/j.arcmed.2006.12.010_bib7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S0140-6736(99)06154-1","article-title":"Cancer in patients on dialysis for endstage renal disease: an international collaborative study","volume":"354","author":"Maisonneuve","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.arcmed.2006.12.010_bib8","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0272-6386(98)70027-7","article-title":"Risk of death among chronic dialysis patients infected with hepatitis C virus","volume":"32","author":"Stehman-Breen","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.arcmed.2006.12.010_bib9","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1681\/ASN.V11101896","article-title":"Prognosis of anti-hepatitis C virus antibody-positive patients on regular hemodialysis therapy","volume":"11","author":"Nakayama","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.arcmed.2006.12.010_bib10","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1111\/j.1365-2036.2004.02290.x","article-title":"Meta-analysis: effect of hepatitis C virus infection on mortality in dialysis","volume":"20","author":"Fabrizi","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.arcmed.2006.12.010_bib11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/j.1600-6143.2004.00652.x","article-title":"Outcome of hepatitis C virus-infected kidney transplant candidates who remain on the waiting list","volume":"4","author":"Bloom","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.arcmed.2006.12.010_bib12","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1046\/j.1365-2036.2003.01780.x","article-title":"Meta-analysis: interferon for the treatment of chronic hepatitis C in dialysis patients","volume":"18","author":"Fabrizi","year":"2003","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.arcmed.2006.12.010_bib13","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1111\/j.1572-0241.2003.07526.x","article-title":"Interferon monotherapy for dialysis patients with chronic hepatitis C: an analysis of the literature on efficacy and safety","volume":"98","author":"Russo","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.arcmed.2006.12.010_bib14","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1478-3231.2005.01225.x","article-title":"Efficacy and tolerance of interferon-alpha in the treatment of chronic hepatitis C in end-stage renal disease patients on hemodialysis","volume":"26","author":"Rocha","year":"2006","journal-title":"Liver Int"},{"key":"10.1016\/j.arcmed.2006.12.010_bib15","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1046\/j.1365-2893.2001.00300.x","article-title":"Ribavirin treatment in dialysis patients with chronic hepatitis C virus infection\u2013a pilot study","volume":"8","author":"Bruchfeld","year":"2001","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.arcmed.2006.12.010_bib16","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/ndt\/16.1.193","article-title":"Safety of interferon and ribavirin therapy in haemodialysis patients with chronic hepatitis C: results of a pilot study","volume":"16","author":"Tan","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.arcmed.2006.12.010_bib17","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/j.1365-2893.2005.00680.x","article-title":"Pegylated interferon and ribavirin treatment for hepatitis C in haemodialysis patients","volume":"13","author":"Bruchfeld","year":"2006","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.arcmed.2006.12.010_bib18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2036.2004.01954.x","article-title":"Pegylated interferon-alpha 2b monotherapy for haemodialysis patients with chronic hepatitis C","volume":"20","author":"Annicchiarico","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.arcmed.2006.12.010_bib19","first-page":"99","article-title":"Peg-interferon alfa 2a (40kDa) in patients on chronic haemodialysis with chronic C hepatitis. Preliminary results","volume":"13","author":"Sporea","year":"2004","journal-title":"Rom J Gastroenterol"},{"key":"10.1016\/j.arcmed.2006.12.010_bib20","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1440-1746.2005.04008.x","article-title":"Efficacy and tolerability of pegylated-interferon alpha-2a in hemodialysis patients with chronic hepatitis C","volume":"21","author":"Kokoglu","year":"2006","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/j.arcmed.2006.12.010_bib21","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/ndt\/gfi231","article-title":"Randomized trial of pegylated interferon alpha-2b monotherapy in hemodialysis patients with chronic hepatitis C","volume":"21","author":"Russo","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.arcmed.2006.12.010_bib22","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1093\/ndt\/gfl072","article-title":"Correspondence","volume":"21","author":"Bruchfeld","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.arcmed.2006.12.010_bib23","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1056\/NEJM199912023412303","article-title":"Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant","volume":"341","author":"Wolfe","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcmed.2006.12.010_bib24","first-page":"1170","article-title":"Efficacy of interferon for chronic hepatitis C virus-related hepatitis in kidney transplant candidates on hemodialysis: results after transplantation","volume":"96","author":"Casanovas-Taltavull","year":"2001","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.arcmed.2006.12.010_bib25","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1159\/000046646","article-title":"Sustained virological and histological response with pretransplant interferon therapy in renal transplant patients with chronic viral hepatitis C","volume":"21","author":"Huraib","year":"2001","journal-title":"Am J Nephrol"},{"key":"10.1016\/j.arcmed.2006.12.010_bib26","first-page":"2704","article-title":"Efficacy and tolerance of interferon-alpha(2b) in the treatment of chronic hepatitis C virus infection in haemodialysis patients. Pre- and post-renal transplantation assessment","volume":"14","author":"Campistol","year":"1999","journal-title":"Nephrol Dial\u00a0Transplant"},{"key":"10.1016\/j.arcmed.2006.12.010_bib27","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1177\/039139880202501211","article-title":"Hepatitis C therapy with long term remission after renal transplantation","volume":"25","author":"Bunnapradist","year":"2002","journal-title":"Int J Artif Organs"},{"key":"10.1016\/j.arcmed.2006.12.010_bib28","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1034\/j.1600-6143.2003.00057.x","article-title":"Pretransplant interferon prevents hepatitis C associated glomerulonephritis in renal allografts by HCV RNA clearance","volume":"3","author":"Cruzado","year":"2003","journal-title":"Am J Transplant"},{"key":"10.1016\/j.arcmed.2006.12.010_bib29","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/00007890-199803150-00011","article-title":"Harmful long term impact of hepatitis C virus infection in kidney transplant recipients","volume":"65","author":"Legendre","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.arcmed.2006.12.010_bib30","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/hep.510290123","article-title":"Impact of hepatitis B and C virus on kidney transplant outcome","volume":"29","author":"Mathurin","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.arcmed.2006.12.010_bib31","first-page":"452","article-title":"Hepatitis C virus antibody status and survival after renal transplant: meta-analysis of\u00a0observational studies","volume":"5","author":"Fabrizi","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.arcmed.2006.12.010_bib32","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/00007890-198802000-00031","article-title":"Adverse effect of low dose prophylactic human recombinant leukocyte interferon-alpha in renal transplant recipients","volume":"45","author":"Kovarik","year":"1988","journal-title":"Transplantation"},{"key":"10.1016\/j.arcmed.2006.12.010_bib33","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1097\/00007890-199505270-00012","article-title":"Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients","volume":"59","author":"Rostaing","year":"1995","journal-title":"Transplantation"},{"key":"10.1016\/j.arcmed.2006.12.010_bib34","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1097\/01.TP.0000131151.07818.D7","article-title":"Ultralow-dose alpha-interferon plus ribavirin for the treatment of active hepatitis C in renal transplant recipients","volume":"77","author":"Shu","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.arcmed.2006.12.010_bib35","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S0168-8278(03)00358-1","article-title":"Successful treatment of hepatitis C after kidney transplantation with combined interferon alpha-2b and ribavirin","volume":"39","author":"Tang","year":"2003","journal-title":"J Hepatol"},{"key":"10.1016\/j.arcmed.2006.12.010_bib36","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1097\/01.TP.0000128911.87538.AA","article-title":"Histopathologic efficacy of ribavirin monotherapy in kidney allograft recipients with chronic hepatitis C","volume":"78","author":"Fontaine","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.arcmed.2006.12.010_bib37","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S0272-6386(03)00422-0","article-title":"Long-term ribavirin therapy in hepatitis C virus-positive renal transplant patients: effects on renal function and liver histology","volume":"42","author":"Kamar","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.arcmed.2006.12.010_bib38","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1056\/NEJM199403173301104","article-title":"Interferon alfa-2a therapy in cryoglobulinemia associated with hepatitis C virus","volume":"330","author":"Misiani","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.arcmed.2006.12.010_bib39","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1038\/ki.1994.471","article-title":"Hepatitis C virus-associated glomerulonephritis. Effect of alpha-interferon therapy","volume":"46","author":"Johnson","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/j.arcmed.2006.12.010_bib40","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1046\/j.1523-1755.2003.00022.x","article-title":"Hepatitis C virus-related cryoglobulinemic glomerulonephritis: long-term remission after antiviral therapy","volume":"63","author":"Rossi","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/j.arcmed.2006.12.010_bib41","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1053\/j.ajkd.2003.11.020","article-title":"Influence of antiviral therapy in HCV-associated cryoglobulinemia MPGN","volume":"43","author":"Alric","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.arcmed.2006.12.010_bib42","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jhep.2004.10.031","article-title":"Treatment with pegylated interferon alpha 2b and ribavirin of HCV-associated mixed cryoglobulinemia: a pilot study","volume":"42","author":"Mazzaro","year":"2005","journal-title":"J Hepatol"}],"container-title":["Archives of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440907001099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0188440907001099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:33:27Z","timestamp":1759260807000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0188440907001099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S0188440907001099"],"URL":"https:\/\/doi.org\/10.1016\/j.arcmed.2006.12.010","relation":{},"ISSN":["0188-4409"],"issn-type":[{"type":"print","value":"0188-4409"}],"subject":[],"published":{"date-parts":[[2007,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of HCV in Patients with Renal Failure","name":"articletitle","label":"Article Title"},{"value":"Archives of Medical Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arcmed.2006.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 IMSS. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}